Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04362852 · ClinicalTrials.gov registry record
Patient Forward Access to Clinical and Technological Research: Genetic Influences on Cancer and Atopic Dermatitis
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 100
- Enrollment target
NCT04362852 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 100 participants.
The verdict
NCT04362852 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This Patient Forward study intends to conduct research to investigate potential genetic factors causing cancer and eczema/atopic dermatitis. The study utilizes a patient-centered design and is led by a collaborative team including The Manton Center for Orphan Disease Research, Inspire, Citizen Genetics and Pfizer. The Manton Center for Orphan Disease Research, a research program at Boston Children's Hospital that focuses on determining the genetic causes of rare and undiagnosed disorders, will work collaboratively with Inspire (inspire.com), a patient-focused research platform and social network with millions of users, to identify and recruit patients and family members for this genetic research study. Participants for this study will be asked to provide health information through surveys, questionnaires and/or interviews, and to provide a genetic sample through a blood draw or saliva sample. The study intends to combine this information to learn more about the genetic drivers in cancer and eczema/atopic dermatitis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2021-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04362852
The ClinicalTrials.gov registry entry for NCT04362852 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04362852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04362852 about?
NCT04362852 is a clinical study titled "Patient Forward Access to Clinical and Technological Research: Genetic Influences on Cancer and Atopic Dermatitis". This Patient Forward study intends to conduct research to investigate potential genetic factors causing cancer and eczema/atopic dermatitis. The study utilizes a patient-centered design and is led by a collaborative team including The Manton Center for Orphan Disease Research, Inspire, Citizen Genet...
What is the current status of trial NCT04362852?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2020-02-01. Estimated completion is 2021-12-31.
Who is sponsoring clinical trial NCT04362852?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.